RNXT
RenovoRx Inc
NASDAQ: RNXT · HEALTHCARE · BIOTECHNOLOGY
$0.85
+2.27% today
Updated 2026-04-30
Market cap
$37.84M
P/E ratio
—
P/S ratio
33.70x
EPS (TTM)
$-0.32
Dividend yield
—
52W range
$1 – $1
Volume
0.4M
RenovoRx Inc (RNXT) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |